In 2009, Moers et al. published the largest ever randomized controlled trial comparing paired kidneys that were either subjected to hypothermic machine perfusion (HMP) or cold storage (CS). This study included 336 kidney pairs that were randomized to either the HMP group or CS group.
Overall, they found that:
- HMP significantly reduced the risk of delayed graft function (DGF)
- Duration of DGF was shorter in the HMP group
- One-year graft survival was significantly higher in the HMP group
They concluded that hypothermic machine perfusion reduces the incidence of DGF as well as reducing the risk of graft failure in the first year, resulting in improved 1-year graft survival compared to kidneys preserved by static cold storage.
Read the full article here: https://www.nejm.org/doi/full/10.1056/NEJMoa0802289
Check out the most recent posts
HMP of Kidneys Compensates for Extended Storage Time: A Single Intervention With a Significant Impact
A study out of Poland by Kruszyna and Richter sought to determine whether with increased cold ischemic times (CIT) and increased use of extended criteria donors (ECD), would hypothermic machine perfusion (HMP) still have the potential to improve outcomes in kidney...
In a multicenter, randomized, controlled trial by Van Rijn, et al, they sought to compare hypothermic oxygenated machine perfusion with static cold storage in liver transplantation from donation after cardiac death (DCD) donors. In this trial, they included 156...
A multicenter retrospective study by de Sandes-Freitas et al. sought to determine the national rate of delayed graft function (DGF) and the associated risk factors with DGF. They studied 8,657 single deceased donor kidney transplants between January 2014 and December...
Savoye et al. performed a retrospective analysis to assess early outcomes of kidney transplants in the French controlled donation after circulatory death (cDCD) program by comparing them to transplants from donation after brain death (DBD) donors in the French...